Repair of large segmental bone defects: BMP-2 gene activated muscle grafts vs. autologous bone grafting

BACKGROUND: Common cell based strategies for the treatment of osseous defects require the isolation and expansion of autologous cells. Since this makes such approaches time-consuming and expensive, we developed a novel expedited technology creating gene activated muscle grafts. We have previously sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Betz, Oliver B, Betz, Volker M, Schröder, Christian, Penzkofer, Rainer, Göttlinger, Michael, Mayer-Wagner, Susanne, Augat, Peter, Jansson, Volkmar, Müller, Peter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750585/
https://www.ncbi.nlm.nih.gov/pubmed/23927083
http://dx.doi.org/10.1186/1472-6750-13-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750585/
https://www.ncbi.nlm.nih.gov/pubmed/23927083
http://dx.doi.org/10.1186/1472-6750-13-65

Ejemplares similares